Oct 30, 2009 | Financial Times
J&J wants deals with rivals to share risk
Johnson & Johnson , the US healthcare group, will in future take more long-term minority stakes and forge alliances with rival pharmaceuticals companies in an effort to share the rising costs and risks of drug development.
Stocks rise as profits at banks provide boost
Investors are finding encouragement from the latest batch of earnings reports. Stocks rose in early trading Wednesday after a handful of banks, including Morgan Stanley, US Bancorp and Wells Fargo, posted better results for the July-September quarter.
Third-quarter profit gives Elan shares a 4.5pc shot in the arm
Shares in drugmaker Elan gained as much as 4.5pc in Dublin trading yesterday after the company reported a third-quarter profit and raised its full-year adjusted earnings forecast.
Taxpayers Fleeced When Leaders Tap Muni Market: Arthur Levitt
State, county and municipal entities across the nation enjoy a privileged position in the debt markets -- the interest they pay is often tax-free and their market is lightly regulated.
SAP = Maintenance Success For Centocor
Miracles do happen. This 2007 SAP-PM implementation for a bulk biopharmaceutical manufacturer has paid for itself through savings in both material and time.
Outlook for Crisis Project Management 2010
To appreciate the impact of crisis project management, it's important to understand how the discipline started.
Are Justin and Jessica Making It Work?
Justin Timberlake and Jessica Biel - are they or aren't they dating? Despite Justin looking rather single the last couple of weeks, usually solo or partying with a bevy of non-Biel babes , the rocky couple was full of cuddles last night.
Elan gains in Dublin after raising forecast
Elan rose as much as 4.5pc in Dublin trading after the drugmaker reported a third-quarter profit and raised its full-year adjusted earnings forecast.
J&J reports modestly higher earnings
Sales slipped 5% to $15.08 billion, from $15.92 billion. According to a recent poll of analysts by FactSet Research, J&J was seen as posting earnings of $1.13 a share, with revenue of $15.19 billion.
Glitter, Glamour, and Fun at J&J Gala
Johnson & Johnson, in partnership with Nursing Spectrum and Gannett Healthcare Group, delivered on its promise to Maryland nurses by raising more than $500,000 at the Promise of Nursing for Maryland gala Sept.
These self-made stars founded companies on our annual list of America's 200 Best Small Companies.
Stocks tread water as traders await earnings
Investors grew cautious Tuesday after quarterly sales at Johnson & Johnson fell short of expectations and an influential analyst stirred worries that bank shares are overheated.
Baxter Beats Again -- the Streak Is Alive
Maybe Wall Street is getting too accustomed to Baxter International beating consensus earnings estimates.
Lowe Brand to Be Erased in U.S. Following Merger With Deutsch
Interpublic Group of Cos. is about to pull the trigger on a merger of its agencies Lowe Worldwide and Deutsch that will do away with the Lowe brand in the U.S., according to people familiar with the matter.
Among the companies whose shares are expected to see active trade in Tuesday's session are Johnson & Johnson Inc., Intel Corp.
Drugmaker Pfizer closes $68B acquisition of Wyeth
Pfizer Inc. and Wyeth have tied the knot in the drug industry's most expensive marriage this year.
Movers & Shakers: Tuesday's biggest gaining and declining stocks
Among the companies whose shares are expected to see active trade in Tuesday's session are AIG, CIT, Goldman Sachs, J&J, Johnson Controls, Pier 1 and Vanda.
DJ industrials pass 10,000 for 1st time in a year
The Dow Jones industrial average has reclaimed 10,000 for the first time in a year.
J&J Q3: Duragesic Sales Down 20% Following Fentanyl Patch Death Warnings
Doctors may finally be getting the message about dangers associated with fentanyl patches, if Johnson & Johnson 's Q3 2009 earnings are any indication.
Abbott Labs profit tops forecasts on greater Humira sales, raises 2009 profit view
Abbott Laboratories said Wednesday it beat its own expectations for the third quarter as sales of its drug Humira continued to climb, along with sales of medical products and nutritional formula for children.
Health-Care Stocks: A Dose of Reality from J&J
It's likely to be some time before health-care companies begin to enjoy the fruits of any economic recovery, judging by Johnson & Johnson's slight third-quarter revenue miss on Oct.
Stocks Pare Losses After Earnings, Goldman Downgrade
The major averages pared early losses, brushing off mixed signals from Johnson & Johnson's earnings and Meredith Whitney's downgrade of Goldman Sachs .
J&J: Planned tax on medical device makers too high
More Sign In to get personalized news, weather and more at myEarthLink. User Sign In Sign in now to: Personalize the content, colors, and layout of your page Choose news headlines, stock quotes, and the weather in your neighborhood Display all the links and information you need in one place Have fun! Over 50 games to play, plus My eBay and My ...
Stock futures lower after J&J misses sales forecasts
Stock futures turned mostly lower on Tuesday as Johnson & Johnson's third-quarter sales figures disappointed investors, offsetting a lift from higher commodity prices that rose with the weaker U.S. dollar.
J&J Net Rises on Medical-Device Sales, Cost Cuts; Revenue Misses Estimates
Johnson & Johnson , the worlda s largest health products company, said profit rose 1.1 percent as cost-cuts offset declining sales.
J&J posts 1 percent profit rise despite sales drop
In this July 14, 2009 file photo, a box of Johnson & Johnson BAND-AID bandages is shown in Boston.
Weekly Outlook: October 12, 2009
With a daily "drive for five" and 13-week up cycle complete, poor reactions to strong earnings thus far hint at profit-taking ahead.
Daily News: J&J Maryland Gala Raises $500,000 to Support Nurses
Johnson & Johnson - in partnership with Gannett Healthcare Group, publishers of Nursing Spectrum, NurseWeek and Nurse.com - delivered on its promise to Maryland nurses by raising more than $500,000 at the Promise of Nursing for Maryland gala Sept.
J&J Wheels and Deals, Awaits New Product Approvals
Johnson & Johnson, the world's biggest healthcare company and a Dow Jones industrial average component, reports earnings for the third quarter Tuesday morning.
Bausch & Lomb Japan Chairman Charged With Tax Evasion on $676K in J&J Options
Mitsuo Hirose , the 72-year-old former president of Johnson & Johnson Japan , was charged with tax evasion, according to two Japanese news services.
Boston Scientific Agrees to Pay J&J $716 Million in Stent Settlement
The march toward peace in the stent wars continues. A couple months ago, we reported that Abbott Laboratories and Medtronic had signed a blockbuster deal that ended all their patent litigation over cardiac stents .
Anyone want to buy Baxter International?
It didn't hire anyone to seek strategic alternatives, but Baxter International Inc.
"Dongle" may sound a bit goofy, but the innocent-seeming technology is emerging as one of the biggest challenges to the mobile telecoms industry in coming years.
It seems that the swine flu pandemic has attracted many large pharmaceutical players towards the vaccine business, the latest being Johnson & Johnson .
Also on Topix